Why nobody honest will say “yes, identical”
The tablet and the pen were approved on different trials, with different doses and different designs. Cross-trial comparison is statistically unreliable, so the accurate statement is narrower: both are FDA-approved for chronic weight management, and both showed clinically meaningful results in their own studies.
What actually differs day to day
The pen is weekly and needs a refrigerator. The tablet is daily and needs an empty stomach, four ounces of water, and a thirty-minute wait. Neither rule set is hard, but one of them will fit your life better, and adherence is where results are actually made.
The switching trap
Because absorption differs so much between routes, dose numbers do not translate. Anyone moving between the pen and the pill does it under a clinician, on a written schedule, never by arithmetic at the kitchen counter.
Semaglutide acts on the GLP-1 receptor – the same signalling your gut uses after a meal.
How to decide
Tell the clinician the true version of your mornings, your needle feelings, and your travel schedule. The right route is the one you will still be taking in month six. See the 30-second film answers for this medication.
Administering it correctly, in plain terms
Follow the instructions your dispensing pharmacy provides with your specific preparation, because concentration differs between products and that is what determines the volume you draw. Most weekly peptide injections are subcutaneous, into fat rather than muscle, using the abdomen away from the navel, the outer thigh, or the back of the upper arm. Rotating the site each week reduces local irritation. Supplies arrive with the shipment: syringes, alcohol swabs, and a sharps container. Units and milligrams are not interchangeable, and confusing them is the most common self-administration error, which is why units versus milligrams exists as its own article. If anything about your dose, volume, or schedule is unclear, contact the pharmacy or your clinician before injecting rather than estimating.
How semaglutide works on the GLP-1 receptor
Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.
FDA has warned about dosing errors reported with compounded GLP-1 products.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
About 10 minutes. Full refund if nothing is prescribed.
Frequently asked questions
Does the pill work as well as the injection?
They were studied in separate trials, so a direct claim of equivalence is not supportable. Both deliver semaglutide; dosing and absorption differ. Your clinician assesses which fits you.
Why would someone choose the tablet?
Some people prefer no needles, no cold chain and a daily routine. Others prefer a single weekly injection. It is a fit question, not a ranking.
Is the dose the same?
No. Oral and injectable semaglutide use different dosing schemes set out in their respective FDA prescribing information.
Can you switch from one to the other?
Only under a clinician's direction. Doses are not interchangeable milligram for milligram.
How do I inject semaglutide?
Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.
Where do you inject semaglutide?
Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.
Ask the question properly
A licensed clinician walks you through what the labels actually show. Rx only.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- ManufacturerWEGOVY (semaglutide) tablets US prescribing information. Novo Nordisk
- FDA databaseDrugs@FDA: search approved labeling for semaglutide
- Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)
- FDA guidanceFDA: Compounding and the FD&C Act, Section 503A
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Wegovy® Tablets
Same medication, different question.
